ramelteon has been researched along with Chemical Dependence in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Araki, R; Funahashi, H; Ishida, Y; Naono-Nagatomo, K; Takeda, R; Taniguchi, H | 1 |
| Naono-Nagatomo, K | 1 |
| Miyamoto, M | 1 |
| Zammit, G | 1 |
| Hirai, K; Kato, K; Miyamoto, M; Nishikawa, H; Nishiyama, K; Yukuhiro, N | 1 |
| De Sousa, A | 1 |
| Cruź, CM; France, CP; Koek, W; McMahon, LR; Weltman, RH | 1 |
| Griffiths, RR; Johnson, MW; Suess, PE | 1 |
3 review(s) available for ramelteon and Chemical Dependence
| Article | Year |
|---|---|
Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.
Topics: Animals; Circadian Rhythm; Electroencephalography; Humans; Indenes; Learning; Memory; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Reward; Sleep Wake Disorders; Substance-Related Disorders | 2009 |
Comparative tolerability of newer agents for insomnia.
Topics: Azabicyclo Compounds; Clinical Trials as Topic; Drug Interactions; Humans; Hypnotics and Sedatives; Indenes; Memory; Piperazines; Psychomotor Performance; Pyridines; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem | 2009 |
[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).].
Topics: Animals; Chronic Disease; Cyclic AMP; Drug Evaluation, Preclinical; Humans; Indenes; Randomized Controlled Trials as Topic; Receptors, Melatonin; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance-Related Disorders; Suprachiasmatic Nucleus | 2010 |
5 other study(ies) available for ramelteon and Chemical Dependence
| Article | Year |
|---|---|
A survey of the effects of ramelteon on benzodiazepine-dependence: Comparison between a ramelteon add-on group and a continuous benzodiazepine administration group.
Topics: Aged; Benzodiazepines; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Middle Aged; Outcome Assessment, Health Care; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders | 2018 |
Response to "Comments on the study: A survey of the effects of ramelteon on benzodiazepine-dependence".
Topics: Benzodiazepines; Humans; Hypnotics and Sedatives; Indenes; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders | 2020 |
Ramelteon dose escalation in a patient with substance misuse.
Topics: Benzodiazepines; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Indenes; Middle Aged; Pyridines; Substance-Related Disorders; Zolpidem | 2012 |
Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzodiazepines; Conditioning, Classical; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Flumazenil; GABA Modulators; Hypnotics and Sedatives; Indenes; Macaca mulatta; Male; Methylcellulose; Midazolam; Neuropsychological Tests; Receptors, Melatonin; Substance-Related Disorders; Time Factors | 2006 |
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
Topics: Administration, Oral; Adult; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Middle Aged; Placebos; Postural Balance; Psychomotor Performance; Receptors, Melatonin; Sleep Stages; Substance Abuse Detection; Substance-Related Disorders; Surveys and Questionnaires; Triazolam | 2006 |